Table 3.

Baseline characteristics of final study cohort

Patients demographics	Total	PMC	RAH	POW
	(N = 133)	(N = 92)	(N = 22)	(N = 19)
Mean age at diagnosis, years	55	53	61	63
Age range, years	19–90	19–90	19–90	27–80
Female to male	01:01.2	01:01.5	1.1:1	02:01
Stage
II	53 (40%)	40	6	7
III	77 (58%)	49	20	8
Unknowna	3 (2%)	3	0	0
Sarcoma subtypes
Undifferentiated pleomorphic sarcoma	53	39	8	6
Liposarcoma	26	15	5	6
Synovial sarcoma	19	18	1	0
Leiomyosarcoma	12	6	4	2
Other	23	14	4	5
Treatment breakdown
Surgery alone	30	4	14	12
Surgery and radiotherapyb	95	86	7	2
Surgery and chemotherapyc	0	0	0	0
Surgery, radiotherapy, and chemotherapyd	8	2	1	5

^aLocalised soft tissue sarcomas with no evidence of metastasis and resectable but missing staging information

^bRadiotherapy delivered in neoadjuvant or adjuvant setting

^cChemotherapy delivered in neoadjuvant or adjuvant setting

^dRadiotherapy and chemotherapy delivered in neoadjuvant or adjuvant setting, concurrently or in sequence